-
From Our LabsJul 19, 2021How to address the culture gap between academia and industry in biomedicineExperts call for significant changes to facilitate the discovery of new treatments.
From Our Labs -
From Our LabsJul 19, 2021Giraffes have high blood pressure. Why don’t they drop dead?A certain leggy resident of the African grasslands is arousing a lot of interest among evolutionary biologists. They believe that study of giraffes' unique features could lead the way to advances in human health.
From Our Labs -
From Our LabsJul 20, 2021Stopping free radicals at their sourceCompounds that block the production of damaging molecules might shed light on their role in disease—and lead to new therapies.
From Our Labs -
From Our LabsJul 19, 2021Five things to look for in a scientific mentorFrom Our Labs -
From Our LabsJul 19, 2021How I built a mini-gut with next to no biology trainingFrom Our Labs -
From Our LabsJul 19, 2021Fixing what’s lost in translationFrom Our Labs -
From Our LabsJul 19, 2021Letters to my younger self: Female scientists share their wisdomAccomplished female scientists at Novartis share their wisdom born from difficult moments in life.
From Our Labs -
From Our LabsJul 20, 2021Nurturing the life science ecosystemFrom Our Labs -
From Our LabsJul 19, 2021Cancer spies find drug-beating covert cellsFrom Our Labs -
From Our LabsJul 20, 2021Turning up the heat on tumorsFrom Our Labs -
From Our LabsJul 20, 2021Vision hackerMaking clinical tools from basic research knowledge is a practice Novartis and FMI researchers pursue. Read how they want to help retinitis pigmentosa patients to see the light.
From Our Labs -
From Our LabsJul 19, 2021Chemical genetics: The sleuthing behind modern drug discoveryResearchers at Novartis are combining modern techniques with an old approach to drug discovery and getting surprising results.
From Our Labs